Back to Results
First PageMeta Content
Chemistry / Organochlorides / Neuroendocrinology / Testosterone / Lactams / 5-alpha reductase / Antiandrogen / Prostate cancer / Finasteride / Endocrine system / Androgens / Medicine


DRAFT REPORT OF THE OECD VALIDATION OF THE RAT HERSHBERGER BIOASSAY: PHASE-2: TESTING OF ANDROGEN AGONISTS, ANDROGEN ANTAGONISTS AND A 5α-REDUCTASE INHIBITOR IN DOSE RESPONSE STUDIES BY MULTIPLE LABORATORIES
Add to Reading List

Document Date: 2008-03-24 10:32:19

Open Document

File Size: 779,46 KB

Share Result on Facebook

City

Washington / DC / Cincinnati / Welfare / /

Company

PARTICPATING LABORATORIES / Procter & Gamble / Mammalian Validation Management Group / Lead Laboratory / Validation Management Group / CVs / Syngenta / CTL Laboratory / MULTIPLE LABORATORIES / /

Country

Germany / France / Japan / United States / Canada / Korea / United Kingdom / Denmark / /

/

Event

FDA Phase / /

Facility

Lead Laboratory / REPORT OF THE LEAD LABORATORY / /

/

IndustryTerm

obvious solution / particular protocol / chemicals / /

Organization

United States Environmental Protection Agency / OECD Secretariat / Environment / Health and Safety Division Environment Directorate Organisation for Economic Co-operation and Development / Working Party on Chemicals / Pesticides and Biotechnology / Research Triangle Park / US Environmental Protection Agency / Chemicals Committee / OECD Task Force on Endocrine Disrupters Testing and Assessment / OECD / /

Person

John Ashby / L. Earl Gray / Jr. / Gary Timm / William Owens / Mike Wade / /

/

Position

VP / VP / SVCG / /

Product

finasteride / Testosterone propionate / Phase-2 / antagonists / /

ProgrammingLanguage

Pascal / /

ProvinceOrState

Montana / /

Technology

standardised protocols / 19 Phase-2 Protocol / Biotechnology / particular protocol / html / /

URL

http /

SocialTag